Revelation Biosciences develops immunologic therapeutics and diagnostics that utilize trained immunity to enhance the body's natural defense mechanisms. Their solutions aim to improve health outcomes by providing targeted interventions for immune-related conditions.
Funding
$4M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Many immune-related conditions lack targeted interventions that effectively harness the body's natural defense mechanisms. Current immunologic therapeutics and diagnostics may not fully utilize trained immunity to improve health outcomes.
Solution
Revelation Biosciences is developing immunologic therapeutics and diagnostics that leverage trained immunity to enhance the body's natural defense mechanisms. Their approach aims to improve patient outcomes by providing targeted interventions for a range of immune-related conditions. The company focuses on harnessing the power of trained immunity to develop innovative solutions.
Target Audience
The primary target audience includes individuals with immune-related conditions and healthcare providers seeking advanced immunologic therapeutics and diagnostics.
Features
- Development of immunologic therapeutics
- Development of immunologic diagnostics
- Utilization of trained immunity to enhance the body's natural defense mechanisms
- Targeted interventions for immune-related conditions